We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Doit-on encore utiliser l'acétate de cyprotérone pour traiter l'hyperandrogénie du syndrome des ovaires polykystiques ? Quelles sont les alternatives ?
- Authors
Chabbert-Buffet, Nathalie
- Abstract
In 2018 the French National Health Database study results were released showing the increased risk of prevalent and incident meningioma in current or past female users of cyproterone acetate. A dose, age and treatment duration effect was shown. Cyproterone acetate indications in the treatment of hirsutism have been limited to severe cases of hirsutism in premenopausal women. In 2020 the French Endocrine Society has updated recommendations for hirsutim care, including alternatives to cyproterone acetate in case of contra indication, and for women worried to use it.
- Subjects
MENINGIOMA; CYPROTERONE acetate; HYPERTRICHOSIS; HYPERANDROGENISM; ENDOCRINE gynecology
- Publication
Médecine de la Reproduction, 2021, Vol 23, Issue 3, p222
- ISSN
2650-8427
- Publication type
Article
- DOI
10.1684/mte.2021.0853